Frederick Financial Consultants’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$558K Sell
2,566
-94
-4% -$20.9K 0.28% 56
2025
Q4
$608K Sell
2,660
-49
-2% -$11.2K 0.33% 50
2025
Q3
$627K Buy
2,709
+68
+3% +$13.8K 0.35% 46
2025
Q2
$490K Buy
2,641
+120
+5% +$22.3K 0.3% 53
2025
Q1
$528K Buy
2,521
+667
+36% +$130K 0.38% 49
2024
Q4
$329K Buy
+1,854
New +$341K 0.26% 56

Other funds holding ABBV

Frederick Financial Consultants's ABBV Position: Q1 2026 in Review

Frederick Financial Consultants reduced its AbbVie (ABBV) stake by 3.5% in Q1 2026, selling an estimated $20.9K and leaving 2,566 shares worth $558K. The position accounts for 0.28% of the portfolio, ranked #56.

Frederick Financial Consultants first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $627K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Frederick Financial Consultants held 2,566 shares of AbbVie worth $558K as of Q1 2026.
  • Frederick Financial Consultants sold 94 AbbVie shares in Q1 2026, an estimated $20.9K.
  • AbbVie made up 0.28% of Frederick Financial Consultants's portfolio in Q1 2026, its #56 holding.
  • Frederick Financial Consultants first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Frederick Financial Consultants's AbbVie position peaked at $627K in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Frederick Financial Consultants's 13F filing for Q1 2026, filed 14 May 2026.